EE277 Cost-Effectiveness of Lanreotide ATG Verse Octreotide for the Treatment of Acromegaly in China
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.524
https://www.valueinhealthjournal.com/article/S1098-3015(22)02728-0/fulltext
Title :
EE277 Cost-Effectiveness of Lanreotide ATG Verse Octreotide for the Treatment of Acromegaly in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02728-0&doi=10.1016/j.jval.2022.09.524
First page :
Section Title :
Open access? :
No
Section Order :
10053